Delivery Order SPE2DB22D3102-SPE2DB24FK9VR
- Not listed
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,464 tablets of Hydroxychloroquine 200 mg. The $2,909.44 firm fixed-price contract has a completion date of September 15, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,065.90 fixed-price contract is for the delivery of 4,559,471,372 units of Hydroxychloroquine 200 mg tablets, with a completion date of December 30, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4,565,661 units of hydroxychloroquine 200 mg tablets. The $1,557.88 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 4, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxychloroquine 200 mg tablets in 100-count bottles, with a ceiling value of $3,909.46 and a completion date of September 3, 2024. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $3,015.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,364,842 units of hydroxychloroquine 200 mg tablets. The contract has a completion date of May 27, 2022 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,632.85 delivery order contract is for the supply of hydroxychloroquine 200 mg tablets. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $12,794 to Amerisourcebergen Drug Corporation for the provision of 50 boxes of 200mg hydroxychloroquine tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is August 17-18, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this requirement for the Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,416.50 to Amerisourcebergen Drug Corporation for 200 milligram tablets of hydroxychloroquine. Amerisourcebergen will deliver 100 tablets of the medication to a location in Conshohocken, Pennsylvania by July 18, 2023 in fulfillment of the contract. As a major division of Amerisourcebergen Corporation, the prime contractor will utilize its extensive distribution network to provide this...
- This federal contract award, with an ID of SPE2DB20D3104|SPE2DB22FV6T9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.34 firm fixed-price delivery order is for the supply of 4,557,140 units of hydroxychloroquine 200mg tablets. The contract has an ultimate completion date of May 9, 2022 and was awarded on May 6, 2022. This award is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Hydroxychloroquine 200 mg tablets. The $1,957.14 Firm Fixed Price Delivery Order is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB24FK9VRDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,492 units of Hydroxychloroquine 200 mg tablets in 100-count bottles. The contract has a potential value of $1,240.87 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/30/24 |